Contrasting Cardinal Health (NYSE:CAH) and Green Cures & Botanical Distribution (OTCMKTS:GRCU)

Green Cures & Botanical Distribution (OTCMKTS:GRCU) and Cardinal Health (NYSE:CAH) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership.

Profitability

This table compares Green Cures & Botanical Distribution and Cardinal Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Green Cures & Botanical Distribution	N/A	N/A	N/A
Cardinal Health	0.70%	-74.45%	4.14%

Insider & Institutional Ownership

87.2% of Cardinal Health shares are held by institutional investors. 0.1% of Cardinal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Green Cures & Botanical Distribution and Cardinal Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Green Cures & Botanical Distribution	N/A	N/A	N/A	N/A	N/A
Cardinal Health	$234.31 billion	0.21	$1.56 billion	$6.63	30.93

Cardinal Health has higher revenue and earnings than Green Cures & Botanical Distribution.

Volatility and Risk

Green Cures & Botanical Distribution has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Cardinal Health has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Green Cures & Botanical Distribution and Cardinal Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Green Cures & Botanical Distribution	0	0	0	0	0.00
Cardinal Health	0	3	12	0	2.80

Cardinal Health has a consensus price target of $206.57, indicating a potential upside of 0.74%. Given Cardinal Health’s stronger consensus rating and higher possible upside, analysts plainly believe Cardinal Health is more favorable than Green Cures & Botanical Distribution.

Summary

Cardinal Health beats Green Cures & Botanical Distribution on 8 of the 10 factors compared between the two stocks.

About Green Cures & Botanical Distribution

Global Roundtable Corporation operates in the health and wellness business. It also provides products and ancillary services in the mental wellness segment and optical-vision medical care. The company was formerly known as Green Cures & Botanical Distribution Inc. and changed its name to Global Roundtable Corporation in May 2023. Global Roundtable Corporation was incorporated in 1986 and is based in Denver, Colorado.

About Cardinal Health

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.